Skip to main content

Home

2021 Virtual Experience
Where Debate & Discussion Translate to Better Treatments
That's a wrap! The 2021 events have concluded.

Thank you to those who participated in the 2021 Great Debates & Updates in Hematologic Malignancies Series. Use the links below to access the virtual platform, claim credits or view conference coverage. We will be announcing 2022 dates and locations in the fall! 

Interactive Format. Practical Implications.

The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, such as multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, and so much more.

 

 

9
Scientific Sessions
15.5
CME Credits
24
Expert Faculty
6
Months of On-Demand Access
Heading
Who Should Attend?
Body

These live educational activities are designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, and myeloid malignancies.

List
Hematologists
Medical Oncologists
Physicians
Physician Assistants
Physicians-in-Training
Oncology Nurses
Pharmacists
GDU HEM
Heading
Featured Topics
Body

As an event best known for its unique, debate-style format, the 2021 agenda features a mix of didactic lectures and debates, examining the latest and most controversial topics across the board in the field of hematologic malignancies. 

List
Multiple Myeloma
Acute Leukemia
Chronic Lymphocytic Leukemia
Lymphoma
Chronic Myeloid Leukemia
Myelodysplastic Syndrome
Myeloproliferative Neoplasms
Special Topics in Hematologic Malignancies
Meet the Chairs
Jessica K. Altman, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
John P. Leonard, MD
Center for Lymphoma and Myeloma
Weill Cornell Medicine
New York, New York
Joseph R. Mikhael, MD, MEd, FRCPC
Translational Genomics Research Institute (TGen)
City of Hope Cancer Center
Phoenix, Arizona
Endorsers

Keep Me Informed